Long Term Cannabis Use Causes Memory Impairment in Mice
Brain imaging studies showed that the drug impairs function in key brain regions involved in learning and memory.
Heavy Metal Test Kits Ready for Cannabis Industry
Testing for cadmium, lead, and mercury is mandated by Health Canada with limits often in parts per million.
Trends in Cannabis Drug Development
Medical cannabis-derived products have the potential to treat pain, which could significantly curb the out-of-control opioid epidemic gripping the nation.
CBD Oil: What You Need to Know
Despite CBD oil’s high profile status, there’s still a lot of confusion about what it actually is, and what it’s made from.
PhytaTech CO, Receives Certification for Pesticide Contamination Testing
Pesticide testing is not currently required in Colorado but, scientists at the lab predict that it will in mandated in the coming months.
Cannabinoid Drug to Become Available for Fibromyalgia Patients in Canada
The drug is already being studied in a Phase 3 Health Canada approved clinical trial for advanced cancer pain.
CBD to be Trialed as Motor Neuron Disease Treatment in Humans
The six-month study will be led by Gold Coast Neurologist, Dr. Arman Sabet who has been involved in many international clinical trials specializing in neuromuscular disorders and stroke.
Brain Changes Responsible for Appetite Effects of Cannabis Identified
Deciphering the ways cannabis acts in the body to alter appetite could lead to new treatments for illness-induced anorexia common in cancer, HIV/AIDS, heart disease, and some metabolic disorders.
Coalition Calls for Sickle Cell Cannabis Clinical Trial
To date, the only cure for SCD is a bone marrow transplant, which is costly and out of reach for most patients.
Digipath Labs Hires New Analytical Laboratory Director
Digipath is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures.
